請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71236
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林欽塘(Chin-Tarng Lin) | |
dc.contributor.author | Bing-Sheng-Lu | en |
dc.contributor.author | 呂秉昇 | zh_TW |
dc.date.accessioned | 2021-06-17T05:00:11Z | - |
dc.date.available | 2028-07-24 | |
dc.date.copyright | 2018-08-30 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-07-26 | |
dc.identifier.citation | 1. (2002). 'Cancer incidence in five continents. Volume VIII.' IARC Sci Publ(155): 1-781.Alonso, S. R., L. Tracey, P. Ortiz, B. Perez-Gomez, J. Palacios, M. Pollan, J. Linares, S. Serrano, A. I. Saez-Castillo, L. Sanchez, R. Pajares, A. Sanchez-Aguilera, M. J. Artiga, M. A. Piris and J. L. Rodriguez-Peralto (2007). 'A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.' Cancer Res 67(7): 3450-3460.
2. Azpiazu, N. and M. Frasch (1993). 'tinman and bagpipe: two homeo box genes that determine cell fates in the dorsal mesoderm of Drosophila.' Genes Dev 7(7B): 1325-1340. 3. Bodmer, R., L. Y. Jan and Y. N. Jan (1990). 'A new homeobox-containing gene, msh-2, is transiently expressed early during mesoderm formation of Drosophila.' Development 110(3): 661-669. 4. Bozkurt, S. U., E. Ayan, F. Bolukbasi, I. Elmaci, N. Pamir and A. Sav (2009). 'Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.' APMIS 117(9): 651-659. 5. Bray, F., M. Haugen, T. A. Moger, S. Tretli, O. O. Aalen and T. Grotmol (2008). 'Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications.' Cancer Epidemiol Biomarkers Prev 17(9): 2356-2365. 6. Cai, L., S. Z. Yu and Z. F. Zhan (2001). 'Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province.' World J Gastroenterol 7(6): 792-795. 7. Cao, Y., X. P. Miao, M. Y. Huang, L. Deng, L. F. Hu, I. Ernberg, Y. X. Zeng, D. X. Lin and J. Y. Shao (2006). 'Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.' BMC Cancer 6: 167. 8. Carter, D. R., A. D. Buckle, K. Tanaka, J. Perdomo and B. H. Chong (2014). 'Art27 interacts with GATA4, FOG2 and NKX2.5 and is a novel co-repressor of cardiac genes.' PLoS One 9(4): e95253. 9. Chang, K. P., S. P. Hao, S. Y. Lin, S. H. Ueng, P. C. Pai, C. K. Tseng, C. Hsueh, M. S. Hsieh, J. S. Yu and N. M. Tsang (2006). 'The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.' Laryngoscope 116(4): 541-546. 10. Chen, C. J., K. Y. Liang, Y. S. Chang, Y. F. Wang, T. Hsieh, M. M. Hsu, J. Y. Chen and M. Y. Liu (1990). 'Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.' Anticancer Res 10(2B): 547-553. 11. Chen, C. Y. and R. J. Schwartz (1995). 'Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, nkx-2.5.' J Biol Chem 270(26): 15628-15633. 12. Chen, L., L. Gallicchio, K. Boyd-Lindsley, X. G. Tao, K. A. Robinson, T. K. Lam, J. G. Herman, L. E. Caulfield, E. Guallar and A. J. Alberg (2009). 'Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review.' Nutr Cancer 61(1): 1-15. 13. Cheng, Y. J., A. Hildesheim, M. M. Hsu, I. H. Chen, L. A. Brinton, P. H. Levine, C. J. Chen and C. S. Yang (1999). 'Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan.' Cancer Causes Control 10(3): 201-207. 14. Cheung, S. T., S. F. Leung, K. W. Lo, K. W. Chiu, J. S. Tam, T. F. Fok, P. J. Johnson, J. C. Lee and D. P. Huang (1998). 'Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.' Int J Cancer 76(3): 399-406. 15. Chin, D., G. M. Boyle, R. M. Williams, K. Ferguson, N. Pandeya, J. Pedley, C. M. Campbell, D. R. Theile, P. G. Parsons and W. B. Coman (2005). 'Novel markers for poor prognosis in head and neck cancer.' Int J Cancer 113(5): 789-797. 16. Cho, E. Y., A. Hildesheim, C. J. Chen, M. M. Hsu, I. H. Chen, B. F. Mittl, P. H. Levine, M. Y. Liu, J. Y. Chen, L. A. Brinton, Y. J. Cheng and C. S. Yang (2003). 'Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1.' Cancer Epidemiol Biomarkers Prev 12(10): 1100-1104. 17. Chu, E. A., J. M. Wu, D. E. Tunkel and S. L. Ishman (2008). 'Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.' Medscape J Med 10(7): 165. 18. Dalla-Torre, C. A., M. Yoshimoto, C. H. Lee, A. M. Joshua, S. R. de Toledo, A. S. Petrilli, J. A. Andrade, S. Chilton-MacNeill, M. Zielenska and J. A. Squire (2006). 'Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.' BMC Cancer 6: 237. 19. Eduardo, B., C. Raquel and M. Rui (2010). 'Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.' Eur Arch Otorhinolaryngol 267(10): 1607-1612. 20. El-Naggar, A. K. (2017). 'Editor's perspective on the 4th edition of the WHO head and neck tumor classification.' J Egypt Natl Canc Inst 29(2): 65-66. 21. Erlic, Z., M. M. Hoffmann, M. Sullivan, G. Franke, M. Peczkowska, I. Harsch, M. Schott, H. E. Gabbert, M. Valimaki, S. F. Preuss, K. Hasse-Lazar, D. Waligorski, M. Robledo, A. Januszewicz, C. Eng and H. P. Neumann (2010). 'Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.' J Clin Endocrinol Metab 95(1): 308-313. 22. Esposito, I., H. Kayed, S. Keleg, T. Giese, E. H. Sage, P. Schirmacher, H. Friess and J. Kleeff (2007). 'Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.' Neoplasia 9(1): 8-17. 23. Feng, B. J., M. Jalbout, W. B. Ayoub, M. Khyatti, S. Dahmoul, M. Ayad, F. Maachi, W. Bedadra, M. Abdoun, S. Mesli, M. Hamdi-Cherif, K. Boualga, N. Bouaouina, L. Chouchane, A. Benider, F. Ben Ayed, D. Goldgar and M. Corbex (2007). 'Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries.' Int J Cancer 121(7): 1550-1555. 24. Friborg, J. T., J. M. Yuan, R. Wang, W. P. Koh, H. P. Lee and M. C. Yu (2007). 'A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese.' Cancer 109(6): 1183-1191. 25. Gale, N., M. Poljak and N. Zidar (2017). 'Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.' Head Neck Pathol 11(1): 23-32. 26. Hadar, T., M. Rahima, E. Kahan, J. Sidi, E. Rakowsky, B. Sarov and I. Sarov (1986). 'Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.' J Med Virol 20(4): 329-339. 27. Harvey, R. P. (1996). 'NK-2 homeobox genes and heart development.' Dev Biol 178(2): 203-216. 28. Helleman, J., M. P. Jansen, K. Ruigrok-Ritstier, I. L. van Staveren, M. P. Look, M. E. Meijer-van Gelder, A. M. Sieuwerts, J. G. Klijn, S. Sleijfer, J. A. Foekens and E. M. Berns (2008). 'Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.' Clin Cancer Res 14(17): 5555-5564. 29. Henle, W., G. Henle, H. C. Ho, P. Burtin, Y. Cachin, P. Clifford, A. de Schryver, G. de-The, V. Diehl and G. Klein (1970). 'Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.' J Natl Cancer Inst 44(1): 225-231. 30. Hildesheim, A., R. J. Apple, C. J. Chen, S. S. Wang, Y. J. Cheng, W. Klitz, S. J. Mack, I. H. Chen, M. M. Hsu, C. S. Yang, L. A. Brinton, P. H. Levine and H. A. Erlich (2002). 'Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan.' J Natl Cancer Inst 94(23): 1780-1789. 31. Hildesheim, A. and C. P. Wang (2012). 'Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.' Semin Cancer Biol 22(2): 107-116. 32. Hirsch, F. R., M. Varella-Garcia, P. A. Bunn, Jr., M. V. Di Maria, R. Veve, R. M. Bremmes, A. E. Baron, C. Zeng and W. A. Franklin (2003). 'Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.' J Clin Oncol 21(20): 3798-3807. 33. Ho, C. K., W. C. Lo, P. H. Huang, M. T. Wu, D. C. Christiani and C. T. Lin (1999). 'Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulphuric acid vapour.' Occup Environ Med 56(6): 426-428. 34. Ho, J. H. (1972). 'Nasopharyngeal carcinoma (NPC).' Adv Cancer Res 15: 57-92. 35. Hsu, C., Y. C. Shen, C. C. Cheng, R. L. Hong, C. J. Chang and A. L. Cheng (2006). 'Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.' Cancer Epidemiol Biomarkers Prev 15(5): 856-861. 36. Hsu, J. L. and S. L. Glaser (2000). 'Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications.' Crit Rev Oncol Hematol 34(1): 27-53. 37. Hu, Y., M. Oscarson, I. Johansson, Q. Y. Yue, M. L. Dahl, M. Tabone, S. Arinco, E. Albano and M. Ingelman-Sundberg (1997). 'Genetic polymorphism of human CYP2E1: characterization of two variant alleles.' Mol Pharmacol 51(3): 370-376. 38. Huang, D. Y., Y. T. Lin, P. S. Jan, Y. C. Hwang, S. T. Liang, Y. Peng, C. Y. Huang, H. C. Wu and C. T. Lin (2008). 'Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression.' J Pathol 214(4): 445-455. 39. Humans, I. W. G. o. t. E. o. C. R. t. (2008). 'IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide).' IARC Monogr Eval Carcinog Risks Hum 97: 3-471. 40. Hwang, C., S. Jang, D. K. Choi, S. Kim, J. H. Lee, Y. Lee, C. D. Kim and J. H. Lee (2009). 'The role of nkx2.5 in keratinocyte differentiation.' Ann Dermatol 21(4): 376-381. 41. Hwang, Y. C., T. Y. Lu, D. Y. Huang, Y. S. Kuo, C. F. Kao, N. H. Yeh, H. C. Wu and C. T. Lin (2009). 'NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression.' Am J Pathol 175(1): 342-354. 42. Ji, M. F., D. K. Wang, Y. L. Yu, Y. Q. Guo, J. S. Liang, W. M. Cheng, Y. S. Zong, K. H. Chan, S. P. Ng, W. I. Wei, D. T. Chua, J. S. Sham and M. H. Ng (2007). 'Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.' Br J Cancer 96(4): 623-630. 43. Jia, W. H., Q. H. Huang, J. Liao, W. Ye, Y. Y. Shugart, Q. Liu, L. Z. Chen, Y. H. Li, X. Lin, F. L. Wen, H. O. Adami, Y. Zeng and Y. X. Zeng (2006). 'Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.' BMC Cancer 6: 178. 44. John, T., G. Liu and M. S. Tsao (2009). 'Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.' Oncogene 28 Suppl 1: S14-23. 45. Kato, Y., Y. Nagashima, Y. Baba, T. Kawano, M. Furukawa, A. Kubota, S. Yanoma, Y. Imagawa-Ishiguro, K. Satake, T. Taguchi, R. Hata, I. Mochimatsu, I. Aoki, Y. Kameda, Y. Inayama and M. Tsukuda (2005). 'Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.' Int J Mol Med 16(2): 263-268. 46. Kim, Y. and M. Nirenberg (1989). 'Drosophila NK-homeobox genes.' Proc Natl Acad Sci U S A 86(20): 7716-7720. 47. Koblinski, J. E., B. R. Kaplan-Singer, S. J. VanOsdol, M. Wu, J. A. Engbring, S. Wang, C. M. Goldsmith, J. T. Piper, J. G. Vostal, J. F. Harms, D. R. Welch and H. K. Kleinman (2005). 'Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.' Cancer Res 65(16): 7370-7377. 48. Komuro, I. and S. Izumo (1993). 'Csx: a murine homeobox-containing gene specifically expressed in the developing heart.' Proc Natl Acad Sci U S A 90(17): 8145-8149. 49. Kuo, Y. S., Y. B. Tang, T. Y. Lu, H. C. Wu and C. T. Lin (2010). 'IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression.' J Pathol 222(3): 299-309. 50. Kwabi-Addo, B., W. Chung, L. Shen, M. Ittmann, T. Wheeler, J. Jelinek and J. P. Issa (2007). 'Age-related DNA methylation changes in normal human prostate tissues.' Clin Cancer Res 13(13): 3796-3802. 51. Lee, A. W., W. Foo, O. Mang, W. M. Sze, R. Chappell, W. H. Lau and W. M. Ko (2003). 'Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality.' Int J Cancer 103(5): 680-685. 52. Levine, P. H., R. R. Connelly and J. M. Easton (1980). 'Demographic patterns for nasopharyngeal carcinoma in the United States.' Int J Cancer 26(6): 741-748. 53. Levine, P. H., G. R. Pearson, M. Armstrong, Z. Bengali, J. Berenberg, J. Easton, H. Goepfert, G. Henle, W. Henle, D. Heffner, A. Huang, V. J. Hyams, A. Lanier, H. B. Neel, B. Pilch, N. Pointek, W. Taylor, H. Terebelo and L. Weiland (1981). 'The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).' Cancer Detect Prev 4(1-4): 307-312. 54. Liebowitz, D. (1994). 'Nasopharyngeal carcinoma: the Epstein-Barr virus association.' Semin Oncol 21(3): 376-381. 55. Lin, T. M., C. S. Yang, J. F. Chiou, S. M. Tu, T. Y. Chen, Y. C. Tu, P. J. Lin, A. Kawamura, Jr. and T. Hirayama (1977). 'Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.' Am J Epidemiol 106(4): 336-339. 56. Liu, F. F. (2002). 'Novel gene therapy approach for nasopharyngeal carcinoma.' Semin Cancer Biol 12(6): 505-515. 57. Liu, H., L. Zhang, Z. Niu, M. Zhou, C. Peng, X. Li, T. Deng, L. Shi, Y. Tan and G. Li (2008). 'Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.' BMC Cancer 8: 253. 58. Lung, H. L., D. K. Bangarusamy, D. Xie, A. K. Cheung, Y. Cheng, M. K. Kumaran, L. Miller, E. T. Liu, X. Y. Guan, J. S. Sham, Y. Fang, L. Li, N. Wang, A. I. Protopopov, E. R. Zabarovsky, S. W. Tsao, E. J. Stanbridge and M. L. Lung (2005). 'THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.' Oncogene 24(43): 6525-6532. 59. Mahdavifar, N., M. Ghoncheh, A. Mohammadian-Hafshejani, B. Khosravi and H. Salehiniya (2016). 'Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.' Osong Public Health Res Perspect 7(6): 360-372. 60. Maillard, C., L. Malaval and P. D. Delmas (1992). 'Immunological screening of SPARC/Osteonectin in nonmineralized tissues.' Bone 13(3): 257-264. 61. McClung, H. M., S. L. Thomas, P. Osenkowski, M. Toth, P. Menon, A. Raz, R. Fridman and S. A. Rempel (2007). 'SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.' Neurosci Lett 419(2): 172-177. 62. Mo, L., H. Wang, G. Huang, H. Zhao and G. Kuang (2005). '[Correlation between expression of the Tiam1 gene and the invasion and metastasis in nasopharyngeal carcinoma].' Lin Chuang Er Bi Yan Hou Ke Za Zhi 19(17): 785-787. 63. Nagel, S., M. Kaufmann, H. G. Drexler and R. A. MacLeod (2003). 'The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).' Cancer Res 63(17): 5329-5334. 64. Nicholson, L. J. and J. D. Morris (1996). 'Role of Epstein-Barr virus gene latent membrane protein in nasopharyngeal carcinoma.' Trends Microbiol 4(4): 132-133. 65. Ning, J. P., M. C. Yu, Q. S. Wang and B. E. Henderson (1990). 'Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China.' J Natl Cancer Inst 82(4): 291-296. 66. Old, L. J., E. A. Boyse, H. F. Oettgen, E. D. Harven, G. Geering, B. Williamson and P. Clifford (1966). 'Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.' Proc Natl Acad Sci U S A 56(6): 1699-1704. 67. Peng, D., C. P. Ren, H. M. Yi, L. Zhou, X. Y. Yang, H. Li and K. T. Yao (2006). 'Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma.' Acta Biochim Biophys Sin (Shanghai) 38(5): 349-355. 68. Porter, P. L., E. H. Sage, T. F. Lane, S. E. Funk and A. M. Gown (1995). 'Distribution of SPARC in normal and neoplastic human tissue.' J Histochem Cytochem 43(8): 791-800. 69. Rhee, D. J., R. I. Haddadin, M. H. Kang and D. J. Oh (2009). 'Matricellular proteins in the trabecular meshwork.' Exp Eye Res 88(4): 694-703. 70. Rich, J. N., C. Hans, B. Jones, E. S. Iversen, R. E. McLendon, B. K. Rasheed, A. Dobra, H. K. Dressman, D. D. Bigner, J. R. Nevins and M. West (2005). 'Gene expression profiling and genetic markers in glioblastoma survival.' Cancer Res 65(10): 4051-4058. 71. Said, N. A., I. Najwer, M. J. Socha, D. J. Fulton, S. C. Mok and K. Motamed (2007). 'SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.' Neoplasia 9(1): 23-35. 72. Sakai, N., M. Baba, Y. Nagasima, Y. Kato, K. Hirai, K. Kondo, K. Kobayashi, M. Yoshida, S. Kaneko, T. Kishida, S. Kawakami, M. Hosaka, Y. Inayama and M. Yao (2001). 'SPARC expression in primary human renal cell carcinoma: upregulation of SPARC in sarcomatoid renal carcinoma.' Hum Pathol 32(10): 1064-1070. 73. Shibata, K., H. Kajiyama, E. Yamamoto, M. Terauchi, K. Ino, A. Nawa and F. Kikkawa (2008). 'Establishment and characterization of an ovarian yolk sac tumor cell line reveals possible involvement of Nkx2.5 in tumor development.' Oncology 74(1-2): 104-111. 74. Song, L. B., J. Li, W. T. Liao, Y. Feng, C. P. Yu, L. J. Hu, Q. L. Kong, L. H. Xu, X. Zhang, W. L. Liu, M. Z. Li, L. Zhang, T. B. Kang, L. W. Fu, W. L. Huang, Y. F. Xia, S. W. Tsao, M. Li, V. Band, H. Band, Q. H. Shi, Y. X. Zeng and M. S. Zeng (2009). 'The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.' J Clin Invest 119(12): 3626-3636. 75. Song, L. B., M. S. Zeng, W. T. Liao, L. Zhang, H. Y. Mo, W. L. Liu, J. Y. Shao, Q. L. Wu, M. Z. Li, Y. F. Xia, L. W. Fu, W. L. Huang, G. P. Dimri, V. Band and Y. X. Zeng (2006). 'Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.' Cancer Res 66(12): 6225-6232. 76. Suzuki, M., C. Hao, T. Takahashi, H. Shigematsu, N. Shivapurkar, U. G. Sathyanarayana, T. Iizasa, T. Fujisawa, K. Hiroshima and A. F. Gazdar (2005). 'Aberrant methylation of SPARC in human lung cancers.' Br J Cancer 92(5): 942-948. 77. Swaroop, A., B. L. Hogan and U. Francke (1988). 'Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33.' Genomics 2(1): 37-47. 78. Thomas, P. S., H. Kasahara, A. M. Edmonson, S. Izumo, M. H. Yacoub, P. J. Barton and R. G. Gourdie (2001). 'Elevated expression of Nkx-2.5 in developing myocardial conduction cells.' Anat Rec 263(3): 307-313. 79. Tiwawech, D., P. Srivatanakul, A. Karalak and T. Ishida (2008). 'Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.' J Clin Virol 42(1): 1-6. 80. Tsao, S. W., C. M. Tsang and K. W. Lo (2017). 'Epstein-Barr virus infection and nasopharyngeal carcinoma.' Philos Trans R Soc Lond B Biol Sci 372(1732). 81. Umar, C. S. (2006). New developments in Epstein-Barr virus research. New York, Nova Science Publishers. 82. Wang, C. S., K. H. Lin, S. L. Chen, Y. F. Chan and S. Hsueh (2004). 'Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.' Br J Cancer 91(11): 1924-1930. 83. Ward, M. H., W. H. Pan, Y. J. Cheng, F. H. Li, L. A. Brinton, C. J. Chen, M. M. Hsu, I. H. Chen, P. H. Levine, C. S. Yang and A. Hildesheim (2000). 'Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan.' Int J Cancer 86(5): 603-609. 84. Watkins, G., A. Douglas-Jones, R. Bryce, R. E. Mansel and W. G. Jiang (2005). 'Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.' Prostaglandins Leukot Essent Fatty Acids 72(4): 267-272. 85. Wong, L. P., K. T. Lai, E. Tsui, K. H. Kwong, R. H. Tsang and E. S. Ma (2005). 'Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?' Int J Cancer 117(3): 515-516. 86. Wu, C. D., H. W. Chou, Y. S. Kuo, R. M. Lu, Y. C. Hwang, H. C. Wu and C. T. Lin (2012). 'Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy.' Oncol Rep 27(1): 94-100. 87. Xu, Z. J., R. S. Zheng, S. W. Zhang, X. N. Zou and W. Q. Chen (2013). 'Nasopharyngeal carcinoma incidence and mortality in China in 2009.' Chin J Cancer 32(8): 453-460. 88. Yamanaka, M., K. Kanda, N. C. Li, T. Fukumori, N. Oka, H. O. Kanayama and S. Kagawa (2001). 'Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.' J Urol 166(6): 2495-2499. 89. Yamashita, K., S. Upadhay, K. Mimori, H. Inoue and M. Mori (2003). 'Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.' Cancer 97(10): 2412-2419. 90. Yang, Z. H., B. Du, Y. S. Wei, J. H. Zhang, B. Zhou, W. B. Liang, J. Jia, B. L. Zhang and L. Zhang (2007). 'Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma.' DNA Cell Biol 26(7): 491-496. 91. Yu, M. C. (1990). 'Diet and nasopharyngeal carcinoma.' FEMS Microbiol Immunol 2(4): 235-242. 92. Yu, M. C., D. H. Garabrant, T. B. Huang and B. E. Henderson (1990). 'Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China.' Int J Cancer 45(6): 1033-1039. 93. Yu, M. C., J. H. Ho, S. H. Lai and B. E. Henderson (1986). 'Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong.' Cancer Res 46(2): 956-961. 94. Yuan, J. M., X. L. Wang, Y. B. Xiang, Y. T. Gao, R. K. Ross and M. C. Yu (2000). 'Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China.' Int J Cancer 85(3): 358-363. 95. Zeng, Z., Y. Zhou, W. Zhang, X. Li, W. Xiong, H. Liu, S. Fan, J. Qian, L. Wang, Z. Li, S. Shen and G. Li (2006). 'Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus.' Genet Med 8(3): 156-160. 96. Zhao, Z. S., Y. Y. Wang, Y. Q. Chu, Z. Y. Ye and H. Q. Tao (2010). 'SPARC is associated with gastric cancer progression and poor survival of patients.' Clin Cancer Res 16(1): 260-268. 97. Zheng, Y. M., P. Tuppin, A. Hubert, D. Jeannel, Y. J. Pan, Y. Zeng and G. de The (1994). 'Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China.' Br J Cancer 69(3): 508-514. 98. Zhou, M., H. Liu, X. Xu, H. Zhou, X. Li, C. Peng, S. Shen, W. Xiong, J. Ma, Z. Zeng, S. Fang, X. Nie, Y. Yang, J. Zhou, J. Xiang, L. Cao, S. Peng, S. Li and G. Li (2006). 'Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.' J Cell Biochem 98(4): 920-930. 99. Zhou, X., J. Cui, V. Macias, A. A. Kajdacsy-Balla, H. Ye, J. Wang and P. N. Rao (2007). 'The progress on genetic analysis of nasopharyngeal carcinoma.' Comp Funct Genomics: 57513. 100. Zhou, Y., K. Nabeshima, K. Koga, M. Aoki, H. Hayashi, M. Hamasaki and H. Iwasaki (2008). 'Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.' Oncol Rep 19(6): 1413-1420. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71236 | - |
dc.description.abstract | 鼻咽癌是一種好發於東南亞,尤其是中國南部、香港、台灣的頭頸部癌並且與許多致病因素有關。環境因素:如廣東高鹽醃製食物以及EBV病毒的感染都是被證實的。鼻咽癌的致病機轉如同其他實質固態瘤一樣目前還是難以解釋。本論文研究目的,就是想找出與鼻咽癌癌化過程中有明顯改變表達的基因。在之前先使用了cDNA微陣列分析(cDNA microarray analysis)的方法,比較鼻咽癌細胞與正常鼻咽黏膜上皮細胞兩者之間的差異,我們發現轉錄因子NKX2.5 基因在鼻咽癌細胞中有較高的表現量。接下來為了探討NKX2.5 是否能夠影響鼻咽癌的癌化現象,首先分析NKX2.5在不同的鼻咽癌細胞株的表現,發現在NPC-TW-01細胞株中比正常鼻黏膜上皮細胞有較高的NKX2.5表達。此外我們透過免疫組織染色以及西方墨點法發現NKX2.5蛋白在NPC-TW-01細胞株與病人檢體中表現量均增加。為了進一步分析NKX2.5的功能在鼻咽癌細胞中所扮演的角色,利用NKX2.5的short hairpin RNA (shRNA) 來抑制NKX2.5的基因表現。在抑制NKX2.5基因表現後可以發現鼻咽癌細胞的增生、轉移以及侵襲能力皆有顯著的降低。接下來在異種移植鼻咽癌腫瘤(NPC xenografts)於免疫缺陷小鼠的實驗中顯示:以抑制NKX2.5 基因表現的shRNA所轉染的鼻咽癌細胞,腫瘤生長速度會有減緩。我們的發現也說明了NKX2.5可能在鼻咽癌癌化過程中扮演一個促進的角色,同時也說明NKX2.5 是鼻咽癌致病機轉中也有所影響包括癌細胞侵襲、增生、轉移。這個新的發現NKX2.5 在鼻咽癌所扮演的重要功能對於此癌症之分子標靶治療及有相當的潛力。 | zh_TW |
dc.description.abstract | Nasopharyngeal carcinoma (NPC) is one of common head and neck cancers in Southeast Asia, particularly Southern China, Hong Kong and Taiwan, believed to have a multifactorial etiology. Environmental factors, consumption of Cantonese salted food and infections of Epstein-Barr virus (EBV) are most documented. The pathogenesis of NPC, like that of most solid tumors, remains elusive. The aim of this study was to identify the significant genes that may be altered during NPC progression. Previously, using cDNA microarray analysis, and we found that the transcription factor NKX2.5. NKX2.5 showed a significant different expression and highly expressed in NPC cell lines than normal nasal mucosal epithelial cells. In order to investigate that whether NKX2.5 gene could affect NPC progression, we observed at first the gene expression in different NPC cells lines using qRT-PCR analysis and found that expression of NKX2.5 in NPC cell lines, especially in NPC-TW01 cell line was highly upregulated. We also demonstrate that the expression level of NKX2.5 protein was increased in NPC-TW01 NPC cell line and NPC biopsy specimens by immunohistochemical staining and western bloting. In order to analysis of the functional role of NKX2.5 in NPC-TW01 cell line, the expression of NKX2.5 was significantly reduced that compared with the control in NPC-TW01 after knockdown of NKX2.5 by NKX2.5 shRNA-lentiviral infection. This in turn resulted in a significant reduction of cell proliferation, invasion, and migration activity of NPC cells. However, in NOD/SCID mice bearing NKX2.5 transfected NPC xenograft, the tumor growth was significantly decreased. Our findings strongly suggest that NKX2.5 may play a role to promote the formation of nasopharyngeal carcinoma of nasopharynx and as a gene in NPC pathogenesis to affect NPC migration, proliferation and invasion. These novel findings of functional role of NKX2.5 may have a potential implication in molecular targeted therapy for NPC. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T05:00:11Z (GMT). No. of bitstreams: 1 ntu-107-R03444006-1.pdf: 8337885 bytes, checksum: a94a613401d71c00f1441d05b306a105 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 口試委員審定書 i
致謝 ii 中文摘要 iv ABSTRACT v List of Figures viii List of Tables ix Introduction 1 Materials and Methods 10 Results 19 Discussion 23 Figures 25 Tables 39 References 40 | |
dc.language.iso | en | |
dc.title | NKX2.5 基因在鼻咽癌之功能分析 | zh_TW |
dc.title | Functional analysis of NKX2.5 gene in Nasopharyngeal Carcinoma | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 吳漢忠(Han-Chung Wu),林中梧(CHUNG-WU LIN),張久瑗(Joanne Jeou-Yuan),楊雅倩(YA-CHIEN YANG) | |
dc.subject.keyword | 鼻咽癌,腫瘤發生,NKX2.5 之體內外功能, | zh_TW |
dc.subject.keyword | Nasopharyngeal carcinoma (NPC),NPC progression,NKX2.5, | en |
dc.relation.page | 49 | |
dc.identifier.doi | 10.6342/NTU201801832 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-07-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 病理學研究所 | zh_TW |
顯示於系所單位: | 病理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 8.14 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。